Mr. Kurzweil is an inventor, entrepreneur, and author, and has created several important technologies in the artificial intelligence field. He has received the National Medal of Technology, the MIT Lemelson Prize, twenty-one honorary doctorates, a Grammy award for his contributions to music technology, and honors from three U.S. Presidents. In 2002, Mr. Kurzweil was inducted into the National Inventors Hall of Fame.
Since 1995, Mr. Kurzweil has served as the Chief Executive Officer of Kurzweil Technologies, Inc., a technology development firm. Beginning January 2013, he also served as a Director of Engineering, and later as Principal Researcher and AI Visionary for Google, a global technology and Internet search company, until 2025. Beginning in 2025, he has served as Chief AI Officer for Beyond Imagination, a humanoid robotics company he co-founded in 2013. Mr. Kurzweil previously served on the boards of directors of Inforte Corp. and Medical Manager Corporation, both of which were publicly-traded.
Mr. Kurzweil has a B.S. in Computer Science and Literature from the Massachusetts Institute of Technology.
What is Ray Kurzweil's net worth?
The estimated net worth of Ray Kurzweil is at least $6.15 million as of March 4th, 2026. Kurzweil owns 12,670 shares of United Therapeutics stock worth more than $6,145,710 as of March 5th. This net worth evaluation does not reflect any other assets that Kurzweil may own. Learn More about Ray Kurzweil's net worth.
How do I contact Ray Kurzweil?
Has Ray Kurzweil been buying or selling shares of United Therapeutics?
Over the course of the past ninety days, Ray Kurzweil has sold $2,401,088.20 in United Therapeutics stock. Most recently, Ray Kurzweil sold 4,910 shares of the business's stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $489.02, for a transaction totalling $2,401,088.20. Following the completion of the sale, the director now directly owns 12,670 shares of the company's stock, valued at $6,195,883.40. Learn More on Ray Kurzweil's trading history.
Who are United Therapeutics' active insiders?
United Therapeutics' insider roster includes Michael Benkowitz (COO), Christopher Causey (Director), Raymond Dwek (Director), James Edgemond (CFO), Richard Giltner (Director), Ray Kurzweil (Director), Paul Mahon (EVP), Jan Malcolm (Director), Nilda Mesa (Director), Judy Olian (Director), Christopher Patusky (Director), Martine Rothblatt (CEO), Louis Sullivan (Director), and Tommy Thompson (Director). Learn More on United Therapeutics' active insiders.
Are insiders buying or selling shares of United Therapeutics?
During the last twelve months, insiders at the biotechnology company sold shares 126 times. They sold a total of 1,153,300 shares worth more than $505,799,128.63. The most recent insider tranaction occured on March, 5th when EVP Paul A Mahon sold 8,300 shares worth more than $4,010,228.00. Insiders at United Therapeutics own 10.3% of the company.
Learn More about insider trades at United Therapeutics. Information on this page was last updated on 3/5/2026.
